Glucagon-like peptide-1
US$ 23.41
can semaglutide cause kidney issues Results from this major trial show that reduced the risk of outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease (CKD). The primary Effects of Once-Weekly Semaglutide on
Description
Critics concerned GLP-1 drugs may give athletes a performance edge How do GLP-1s work
Who May Be a Candidate for Peptide Therapy
The drug is administered as a weekly injection and possesses a safety profile comparable to other GLP-1 therapies
Berberine may potentiate glucose-lowering effects of diabetes medications, increasing hypoglycemia risk when combined with insulin, sulfonylureas, or meglitinides
